Trials / Unknown
UnknownNCT03391817
FAECAL MICROBIOTA TRANSPLANTATION IN OBESITY
FAECAL MICROBIOTA TRANSPLANTATION IN THE TREATMENT OF MORBID OBESITY
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Joint Authority for Päijät-Häme Social and Health Care · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
40 patients meeting the criteria for obesity surgery are enrolled. Fecal microbiota transplantation (FMT) will be administered in gastroscopy 6 months before obesity surgery. 20 of the patients will receive a fecal transplant of a thin donor and 20 will receive placebo - a transplant made of their on feces. Changes in weight, laboratory values, general well being and stool microbiota will be measured up to one year after the surgery; one and a half years after FMT. The hypothesis is that FMT and the change in gut microbiota will help to reduce and maintain lower weight.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fecal microbiota transplantation | Fecal microbiota transplantation administered in gastroscopy |
Timeline
- Start date
- 2018-01-19
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2018-01-05
- Last updated
- 2019-08-15
Locations
2 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT03391817. Inclusion in this directory is not an endorsement.